Study Evaluating HKI-272 Administered to Healthy Subjects

Phase 1

Completed

• Conditions: Healthy

• Registration Number: NCT00366600
• Lead Sponsor: Puma Biotechnology, Inc.

Brief Summary

Safety and tolerability of HKI-272 in healthy subjects; the influence of food intake on the same.

Detailed Description

Not available

Study Timeline

• Study Start: 2006-07
• Study First Submitted: 2006-08-17
• Study First Submitted QC: 2006-08-18
• Study First Posted: 2006-08-21
• Primary Completion: 2006-12
• Study Completion: 2006-12
• Status Verified: 2017-09
• Last Update Submitted: 2017-09-06
• Last Update Posted: 2017-09-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 56

Inclusion Criteria

• Healthy

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Pharmacokinetics; safety and tolerability; influence of food on the same.

Trial Locations

Locations (1)

Northwest Kinetics; 🇺🇸 Tacoma, Washington, United States